Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | POLB | P06746 | 2/20 | 0.46 |
| ▸ | TSHR | P16473 | 1/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.46 |
| ▸ | F2 | P00734 | 1/20 | 0.46 |
| ▸ | DPP4 | P27487 | 1/20 | 0.46 |
| ▸ | CTSD | P07339 | 1/20 | 0.45 |
| ▸ | NPC1L1 | Q9UHC9 | 4/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TP53 | P04637 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.39 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | VDR | P11473 | 1/20 | 0.38 |
| ▸ | GPBAR1 | Q8TDU6 | 1/20 | 0.38 |
| ▸ | POLA1 | P09884 | 1/20 | 0.38 |
| ▸ | TOP2A | P11388 | 1/20 | 0.38 |
| ▸ | TOP2B | Q02880 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22872155 | 1.00 | POLB (0.46) | POLBTSHRTDP1F2DPP4 | |
| SCHEMBL12136662 | 1.00 | POLB (0.46) | POLBTSHRTDP1F2DPP4 | |
| SCHEMBL11117436 | 0.92 | NPC1L1 (0.41) | POLBTSHRTDP1F2DPP4 | |
| SCHEMBL11116663 | 0.92 | NPC1L1 (0.41) | POLBTSHRTDP1F2DPP4 | |
| SCHEMBL11115189 | 0.91 | NPC1L1 (0.42) | POLBTSHRTDP1F2DPP4 | |
| SCHEMBL11114829 | 0.91 | NPC1L1 (0.42) | POLBTSHRTDP1F2DPP4 | |
| SCHEMBL22872156 | 0.89 | NPC1L1 (0.43) | TDP1NPC1L1MEN1USP2LMNA | |
| SCHEMBL9827579 | 0.89 | NPC1L1 (0.45) | TDP1NPC1L1MEN1USP2LMNA | |
| SCHEMBL10425066 | 0.89 | NPC1L1 (0.42) | NPC1L1MEN1USP2LMNATP53 | |
| SCHEMBL10425065 | 0.89 | NPC1L1 (0.42) | NPC1L1MEN1USP2LMNATP53 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9573972-B2 | Nurotoxic sterol glycosides | NEURODYN, INC. (CA) | 2017-02-21 | — | — | US | disclosed |
| US-20110280805-A1 | NEUROTOXIC STEROL GLYCOSIDES | NEURODYN, INC. (CA) | 2011-11-17 | — | — | US | disclosed |
| WO-2010048710-A1 | NEUROTOXIC STEROL GLYCOSIDES | NEURODYN, INC. (CA) | 2010-05-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110280805-A1 | NEUROTOXIC STEROL GLYCOSIDES | CYP27A1, CYP46A1, NR1H3 | POLB 4257/4885TSHR 3509/4885TDP1 705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.